1980
DOI: 10.1084/jem.151.5.1275
|View full text |Cite
|
Sign up to set email alerts
|

The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus.

Abstract: The native capsular polysaccharide antigen of type III, group B Streptococcus contains a terminal sialic acid residue on each repeating unit that masks all end-group galactopyranose residues and prevents alternative pathway complement activation by adult human sera in the absence of type-specific antibody. The critical role of the sialic acid residues in allowing the organism to evade activating the alternative complement pathway was shown when neuraminidase treatment of the organism converted the bacteria to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

8
113
2

Year Published

1985
1985
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 185 publications
(123 citation statements)
references
References 38 publications
8
113
2
Order By: Relevance
“…Low concentrations of Ab to most mastitis pathogens are usually found in milk, but it is not known if Ab may be a limiting factor for complementdependent bactericidal activity. In most cases, the activation of the complement in the presence of Ab is by CP, but rather high concentrations of Ab can also induce the deposition of C3 on bacteria through AP, for example on type III S. agalactiae [25], or on certain strains of mastitis isolates of E. coli [44]. Depending on the strain, the complement alone was sufficient or the complement plus Ab were necessary to kill serum-sensitive E. coli [44].…”
Section: Bactericidal and Hemolytic Activities In Normal Milkmentioning
confidence: 99%
“…Low concentrations of Ab to most mastitis pathogens are usually found in milk, but it is not known if Ab may be a limiting factor for complementdependent bactericidal activity. In most cases, the activation of the complement in the presence of Ab is by CP, but rather high concentrations of Ab can also induce the deposition of C3 on bacteria through AP, for example on type III S. agalactiae [25], or on certain strains of mastitis isolates of E. coli [44]. Depending on the strain, the complement alone was sufficient or the complement plus Ab were necessary to kill serum-sensitive E. coli [44].…”
Section: Bactericidal and Hemolytic Activities In Normal Milkmentioning
confidence: 99%
“…The developing reagent consisted of 0.4 mg/mL of o-phenylenediamine in 0.2 M Na2HP04 (pH 5.0 with 0.1 M citric acid), containing 0. 4 Biochemical assay for reactivity of C3 thiolester bond. Nucleophilic amines, such as CH3NH2, are inherently reactive with thiolester bonds; binding of the nucleophile is stoichiometric, with I mol of the nucleophile covalently bound for each mol of thiolester disrupted (20).…”
Section: Methodsmentioning
confidence: 99%
“…This predisposition to infection is ascribable, at least in part, to age-related defects in host defense (2, 3). Primary among humoral defenses are the complement proteins, which serve as opsonins for common neonatal pathogens such as the group B Streptococcus or the K1 capsular serotype of Escherichia coli (4,5). …”
mentioning
confidence: 99%
“…The importance of PMNs and specific Ab in host defense against III GBS is well recognized. [1][2][3] Neutropenia is a clinical feature of GBS sepsis that has been associated with poor outcome. 36 Cairo et al 37,38 investigated the potential role of leukocyte transfusions to treat infants with neonatal sepsis.…”
Section: Discussionmentioning
confidence: 99%
“…However, previous studies suggest that these components of host defense are deficient in the neonate. 2,3 Furthermore, there are qualitative and quantitative deficiencies in PMN function in neonates. 4 -6 Cytokines, such as tumor necrosis factor-␣ (TNF-␣), granulocyte colony-stimulating factor (G-CSF), and granulocyte-macrophage colony-stimulating factor (GM-CSF), augment the bactericidal activity of PMNs from adults against Staphylococcus aureus, nontypable Hemophilus influenzae, Legionella pneumophila, and Candida albicans.…”
mentioning
confidence: 99%